NAMPT inhibitor-linker 2 is used as a payload component in antibody-drug conjugates (ADCs), specifically in ADC-4, which combines this inhibitor-linker with an anti-c-Kit monoclonal antibody. ADC-4 exhibits potent anti-proliferative activity against c-Kit-expressing cancer cell lines such as GIST-T1 and NCI-H526, with IC50 values of <7 pM and 40 pM, respectively. It inhibits GIST-T1 cell proliferation at concentrations ranging from 0.01 nM to 10 nM over 144 hours without affecting the cell cycle. In vivo, ADC-4 (20 mg/kg, i.v., once daily for 28 days) is well tolerated and induces tumor stasis in SCID-bg mice bearing GIST-T1 xenografts, significantly suppressing tumor growth.